• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用大规模基因数据库研究血管性血友病的人群患病率及突变图谱。

Population-based prevalence and mutational landscape of von Willebrand disease using large-scale genetic databases.

作者信息

Seidizadeh Omid, Cairo Andrea, Baronciani Luciano, Valenti Luca, Peyvandi Flora

机构信息

Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy.

Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.

出版信息

NPJ Genom Med. 2023 Oct 16;8(1):31. doi: 10.1038/s41525-023-00375-8.

DOI:10.1038/s41525-023-00375-8
PMID:37845247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10579253/
Abstract

Von Willebrand disease (VWD) is a common bleeding disorder caused by mutations in the von Willebrand factor gene (VWF). The true global prevalence of VWD has not been accurately established. We estimated the worldwide and within-population prevalence of inherited VWD by analyzing exome and genome data of 141,456 individuals gathered by the genome Aggregation Database (gnomAD). We also extended our data deepening by mining the main databases containing VWF variants i.e., the Leiden Open Variation Database (LOVD) and the Human Gene Mutation Database (HGMD) with the goal to explore the global mutational spectrum of VWD. A total of 4,313 VWF variants were identified in the gnomAD population, of which 505 were predicted to be pathogenic or already reported to be associated with VWD. Among the 282,912 alleles analyzed, 31,785 were affected by the aforementioned variants. The global prevalence of dominant VWD in 1000 individuals was established to be 74 for type 1, 3 for 2A, 3 for 2B and 6 for 2M. The global prevalences for recessive VWD forms (type 2N and type 3) were 0.31 and 0.7 in 1000 individuals, respectively. This comprehensive analysis provided a global mutational landscape of VWF by means of 927 already reported variants in the HGMD and LOVD datasets and 287 novel pathogenic variants identified in the gnomAD. Our results reveal that there is a considerably higher than expected prevalence of putative disease alleles and variants associated with VWD and suggest that a large number of VWD patients are undiagnosed.

摘要

血管性血友病(VWD)是一种常见的出血性疾病,由血管性血友病因子基因(VWF)突变引起。VWD在全球的真实患病率尚未准确确定。我们通过分析基因组聚合数据库(gnomAD)收集的141456名个体的外显子组和基因组数据,估计了遗传性VWD在全球和特定人群中的患病率。我们还通过挖掘包含VWF变异的主要数据库,即莱顿开放变异数据库(LOVD)和人类基因突变数据库(HGMD),深化了我们的数据,目的是探索VWD的全球突变谱。在gnomAD人群中总共鉴定出4313个VWF变异,其中505个被预测为致病性变异或已报告与VWD相关。在分析的282912个等位基因中,有31785个受上述变异影响。1000人中1型显性VWD的全球患病率确定为74,2A型为3,2B型为3,2M型为6。隐性VWD形式(2N型和3型)在1000人中的全球患病率分别为0.31和0.7。这项综合分析通过HGMD和LOVD数据集中已报告的927个变异以及gnomAD中鉴定出的287个新的致病变异,提供了VWF的全球突变图谱。我们的结果表明,与VWD相关的假定疾病等位基因和变异的患病率大大高于预期,并表明大量VWD患者未被诊断出来。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/433f/10579253/4204d1cf917c/41525_2023_375_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/433f/10579253/188cc655976e/41525_2023_375_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/433f/10579253/88e1e199d23d/41525_2023_375_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/433f/10579253/4204d1cf917c/41525_2023_375_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/433f/10579253/188cc655976e/41525_2023_375_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/433f/10579253/88e1e199d23d/41525_2023_375_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/433f/10579253/4204d1cf917c/41525_2023_375_Fig3_HTML.jpg

相似文献

1
Population-based prevalence and mutational landscape of von Willebrand disease using large-scale genetic databases.利用大规模基因数据库研究血管性血友病的人群患病率及突变图谱。
NPJ Genom Med. 2023 Oct 16;8(1):31. doi: 10.1038/s41525-023-00375-8.
2
Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.血管性血友病的特征、分类及治疗:文献与个人经验的批判性评估
Semin Thromb Hemost. 2005 Nov;31(5):577-601. doi: 10.1055/s-2005-922230.
3
Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease.遗传性2A型、2B型、2C型、2D型、2E型、2M型、2N型和2U型(无法分类)血管性血友病的分类与特征描述
Clin Appl Thromb Hemost. 2006 Oct;12(4):397-420. doi: 10.1177/1076029606293422.
4
Laboratory diagnosis and molecular classification of von Willebrand disease.血管性血友病的实验室诊断与分子分类
Acta Haematol. 2009;121(2-3):71-84. doi: 10.1159/000214846. Epub 2009 Jun 8.
5
How we diagnose 2M von Willebrand disease (VWD): Use of a strategic algorithmic approach to distinguish 2M VWD from other VWD types.我们如何诊断 2M 型血管性血友病(VWD):使用策略性算法来区分 2M VWD 与其他 VWD 类型。
Haemophilia. 2021 Jan;27(1):137-148. doi: 10.1111/hae.14204. Epub 2020 Nov 20.
6
Clinical and laboratory phenotype variability in type 2M von Willebrand disease.2M型血管性血友病的临床和实验室表型变异性
J Thromb Haemost. 2017 Aug;15(8):1559-1566. doi: 10.1111/jth.13742. Epub 2017 Jun 23.
7
Clinical significance of slightly reduced von Willebrand factor activity.血管性血友病因子活性轻度降低的临床意义。
Pol Arch Intern Med. 2020 Mar 27;130(3):225-231. doi: 10.20452/pamw.15162. Epub 2020 Jan 28.
8
Molecular genetics of type 2 von Willebrand disease.2型血管性血友病的分子遗传学
Int J Hematol. 2002 Jan;75(1):9-18. doi: 10.1007/BF02981973.
9
Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.隐性严重1型和3型血管性血友病(VWD)、无症状杂合子携带者与血型O相关的血管性血友病因子缺乏症以及显性1型VWD的特征分析
Clin Appl Thromb Hemost. 2006 Jul;12(3):277-95. doi: 10.1177/1076029606291401.
10
The molecular analysis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organisation Haemophilia Genetics Laboratory Network.血管性血友病的分子分析:英国血友病中心医生组织血友病遗传学实验室网络指南
Haemophilia. 2008 Sep;14(5):1099-111. doi: 10.1111/j.1365-2516.2008.01813.x. Epub 2008 Jul 14.

引用本文的文献

1
Comparison of genotypes and phenotypes for von Willebrand factor gene variants using Japanese genome database.利用日本基因组数据库比较血管性血友病因子基因变异的基因型和表型
Blood Vessel Thromb Hemost. 2025 Apr 10;2(3):100070. doi: 10.1016/j.bvth.2025.100070. eCollection 2025 Aug.
2
Genetic analysis using long-read sequencing to overcome the difficulties in gene.使用长读长测序进行基因分析以克服基因研究中的困难。
Res Pract Thromb Haemost. 2025 May 17;9(4):102888. doi: 10.1016/j.rpth.2025.102888. eCollection 2025 May.
3
Clinical utility of panel-based genetic sequencing for von Willebrand disease.

本文引用的文献

1
A need to increase von Willebrand disease awareness: vwdtest.com - A global initiative to help address this gap.提高对血管性血友病的认识的必要性:vwdtest.com——一项旨在填补这一空白的全球倡议。
Blood Rev. 2023 Mar;58:101018. doi: 10.1016/j.blre.2022.101018. Epub 2022 Oct 1.
2
Phenotypic and genetic characterizations of the Milan cohort of von Willebrand disease type 2.Milan 队列 von Willebrand 病 2 型的表型和基因特征。
Blood Adv. 2022 Jul 12;6(13):4031-4040. doi: 10.1182/bloodadvances.2022007216.
3
Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program.
基于基因panel测序在血管性血友病诊断中的临床应用
Res Pract Thromb Haemost. 2025 Mar 12;9(2):102730. doi: 10.1016/j.rpth.2025.102730. eCollection 2025 Feb.
4
Functional characterisation of missense ceruloplasmin variants and real-world prevalence assessment of Aceruloplasminemia using population data.运用群体数据对铜蓝蛋白错义变异体进行功能特性分析及对无铜蓝蛋白血症进行真实世界患病率评估。
EBioMedicine. 2025 Mar;113:105625. doi: 10.1016/j.ebiom.2025.105625. Epub 2025 Mar 4.
5
Challenges and considerations of genetic testing in von Willebrand disease.血管性血友病基因检测的挑战与考量
Res Pract Thromb Haemost. 2025 Jan 16;9(1):102686. doi: 10.1016/j.rpth.2025.102686. eCollection 2025 Jan.
6
Global prevalence of platelet-type von Willebrand disease.血小板型血管性血友病的全球患病率。
Res Pract Thromb Haemost. 2025 Jan 16;9(1):102682. doi: 10.1016/j.rpth.2025.102682. eCollection 2025 Jan.
7
von Willebrand disease.血管性血友病。
Nat Rev Dis Primers. 2024 Jul 25;10(1):51. doi: 10.1038/s41572-024-00536-8.
8
Variant p.Tyr1584Cys: a frequent von Willebrand factor variant in search of von Willebrand disease.p.Tyr1584Cys变异体:一种常见的血管性血友病因子变异体,探寻血管性血友病病因。
Res Pract Thromb Haemost. 2024 May 24;8(4):102451. doi: 10.1016/j.rpth.2024.102451. eCollection 2024 May.
9
Global prevalence of hereditary thrombotic thrombocytopenic purpura determined by genetic analysis.通过基因分析确定遗传性血栓性血小板减少性紫癜的全球患病率。
Blood Adv. 2024 Aug 27;8(16):4386-4396. doi: 10.1182/bloodadvances.2024013421.
10
Application of genetic testing for the diagnosis of von Willebrand disease.遗传性血管性血友病(von Willebrand 病)的基因检测应用。
J Thromb Haemost. 2024 Aug;22(8):2115-2128. doi: 10.1016/j.jtha.2024.05.006. Epub 2024 May 16.
美国 Zimmerman 项目中 3 型血管性血友病家系的分子发病机制和异质性。
J Thromb Haemost. 2022 Jul;20(7):1576-1588. doi: 10.1111/jth.15713. Epub 2022 Apr 6.
4
The Manifold Cellular Functions of von Willebrand Factor.血管性血友病因子的多功能性。
Cells. 2021 Sep 8;10(9):2351. doi: 10.3390/cells10092351.
5
Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.3WINTERS-IPS 研究中登记的 3 型血管性血友病欧洲和伊朗患者的基因型。
Blood Adv. 2021 Aug 10;5(15):2987-3001. doi: 10.1182/bloodadvances.2020003397.
6
CADD-Splice-improving genome-wide variant effect prediction using deep learning-derived splice scores.使用深度学习衍生的剪接分数提高 CADD-Splice 全基因组变异效应预测。
Genome Med. 2021 Feb 22;13(1):31. doi: 10.1186/s13073-021-00835-9.
7
Estimated birth prevalence of Menkes disease and ATP7A-related disorders based on the Genome Aggregation Database (gnomAD).基于基因组聚合数据库(gnomAD)估计的门克斯病和ATP7A相关疾病的出生患病率。
Mol Genet Metab Rep. 2020 Jun 5;24:100602. doi: 10.1016/j.ymgmr.2020.100602. eCollection 2020 Sep.
8
The mutational constraint spectrum quantified from variation in 141,456 humans.从 141456 名人类个体的变异中量化的突变约束谱。
Nature. 2020 May;581(7809):434-443. doi: 10.1038/s41586-020-2308-7. Epub 2020 May 27.
9
High prevalence of cancer-associated TP53 variants in the gnomAD database: A word of caution concerning the use of variant filtering.gnomAD 数据库中癌症相关 TP53 变异的高发生率:关于使用变异过滤需谨慎。
Hum Mutat. 2019 May;40(5):516-524. doi: 10.1002/humu.23717. Epub 2019 Mar 28.
10
Use of Big Data to Estimate Prevalence of Defective DNA Repair Variants in the US Population.利用大数据估计美国人群中 DNA 修复缺陷变异的流行率。
JAMA Dermatol. 2019 Jan 1;155(1):72-78. doi: 10.1001/jamadermatol.2018.4473.